Showing results (91-100 of 530) with videos related to

Sort By:
Pageof 53
BMC Dermatology|August 18, 2017
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)Maria Schneeweiss, Joseph F Merola, Elizabeth W Karlson, et al.
The Journal of Arthroplasty|January 30, 2003
Effectiveness of clinical pathways for total knee and total hip arthroplasty: literature reviewStephen Kim, Elena Losina, Daniel H Solomon, et al.
Arthritis Research & Therapy|February 23, 2010
Bisphosphonates and risk of atrial fibrillation: a meta-analysisSeo Young Kim, Min Jung Kim, Suzanne M Cadarette, et al.
Pharmacoepidemiology and Drug Safety|May 28, 2016
Validation of claims-based algorithms for gout flaresLindsey A MacFarlane, Chih-Chin Liu, Daniel H Solomon, et al.
Rheumatology (Oxford, England)|December 12, 2024
Coronary artery calcium and atherosclerotic cardiovascular disease risk scores in patients with calcium pyrophosphate deposition diseaseSara K Tedeschi, Keigo Hayashi, Hongshu Guan, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2020
Sleep medications and sleep disturbances across middle aged pre- or peri-menopausal women of different race and ethnicities: A SWAN pharmacoepidemiology cohort studyDaniel H Solomon, Kristine Ruppert, Rasa Kazlauskaite, et al.
Annals of the Rheumatic Diseases|May 9, 2024
Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropoutSara K Tedeschi, Keigo Hayashi, Yuqing Zhang, et al.
The American Journal of Medicine|December 25, 2003
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?Daniel H Solomon, Sebastian Schneeweiss, Robert J Glynn, et al.
The Journal of Rheumatology|April 3, 2003
The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patientsDaniel H Solomon, Robert J Glynn, Rhonda Bohn, et al.
Arthritis Care & Research|November 1, 2012
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsiaKristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, et al.
Pageof 53